Ergomed PLC
LSE:ERGO

Watchlist Manager
Ergomed PLC Logo
Ergomed PLC
LSE:ERGO
Watchlist
Price: 1 346 GBX Market Closed
Market Cap: 701.1m GBX

Ergomed PLC
Investor Relations

Ergomed Plc is a clinical stage development company, which provides specialist services to the pharmaceutical and biotechnology industries spanning all phases of clinical development, post-approval pharmacovigilance, and medical information. The company is headquartered in Guildford, Surrey. The company went IPO on 2014-07-15. The firm operates through two segments: Clinical Research Services (CRO) and Pharmacovigilance (PV). CRO segment is the process of developing medical therapies, drugs and knowledge for safe use in healthcare. PV segment is engaged in the activities relating to the detection, understanding and prevention of adverse effects or other drug-related problems throughout its lifecycle. The firm operates approximately 24 offices around the world, providing its services in over 100 countries globally. The company operates in North America, United Kingdom and Europe, Middle East and Africa, and Asia. The Company’s subsidiaries include Ergomed GmbH, Ergomed Sp. z o.o, Ergomed d.o.o. Beograd, Ergomed Clinical Research Inc., MS Clinical Services, LLC and MedSource UK Ltd.

Show more
Loading
ERGO
FTSE All Share Index
1Y 3Y 5Y 10Y 15Y 20Y

Earnings Calls

No Earnings Calls Available

Management

Dr. Miroslav Reljanovic
Founder & Exec. Chairman
No Bio Available
Mr. Richard T. Barfield
CFO & Exec. Director
No Bio Available
Mr. Michael William Spiteri
Chief Transformation & Technology Officer
No Bio Available
Mr. Shaun Hopgood
Chief Information Officer
No Bio Available
Dr. Michael Forstner
Head of Risk Management & Pharmacoepidemiology
No Bio Available
Ms. Sally Amanuel
Pres of PrimeVigilance
No Bio Available
Dr. Gordana Tonkovic
Pres of Clinical Research
No Bio Available
Ms. Ronel Steyn
Sr. VP of Global Devel.
No Bio Available
Keith Byrne
Sr. Vice-Pres of Capital Markets & Strategy
No Bio Available
Jonathan Curtain
Deputy CFO
No Bio Available

Contacts

Address
SURREY
Guildford
1 Occam Court, Occam Road
Contacts
+441483503205.0
www.ergomedplc.com
sparklesyt

See Also

Summary
ERGO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ERGO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ERGO stock valuation using valuation multiples.
Wall Street Estimates
ERGO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ERGO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.